IsoTOP-ABPP is a derivative of activity-based protein profiling (ABPP), a pioneering technology for interrogating protein activity directly in complex biological systems. In general, ABPP probes contain three elements: (1) a reactive warhead for covalently labeling target proteins; (2) a reporter tag for affinity purification or fluorescence detection; and, (3) a linker to minimize steric hindrance between the reporter and reactive groups [30,31]. Early ABPP methods utilized reactive warheads targeting a specific enzyme family, such as the fluorophosphonate probe for the serine hydrolases [32]. In latter iterations, more reactive and promiscuous electrophiles were utilized [33], culminating in the use of an iodoacetamide-alkyne (IA-alkyne) probe for modification of reactive cysteines in the proteome. The isoTOP-ABPP platform couples an IA-alkyne probe with an isotopically tagged cleavable linker, enabling the selective enrichment, release, and mass-spectrometry (MS) relative quantification of IA-labeled peptides from two samples. The isoTOP-ABPP platform involves the following steps: (1) treatment of lysates with IA-alkyne to label reactive cysteines; (2) conjugation of IA-labeled cysteines in control and experimental samples to isotopically differentiated cleavable azide-biotin tags using copper-catalyzed azide-alkyne cycloaddition (CuAAC) [34]; (3) enrichment of IA-labeled proteins on streptavidin beads, followed by on-bead tryptic digestion, and linker cleavage to release IA-labeled peptides; and, (4) analysis of the resulting isotopically heavy and light peptide pairs using LC/LCMS/MS to quantify reactivity differences in two samples using light:heavy isotopic ratios [1] (Figure 1).
(A) General isoTOP-ABPP workflow. Reactive cysteine residues on two proteome samples are labeled with IA-alkyne, followed by CuAAC with an isotopically heavy or light biotin-azide cleavable linker. The two lysates are combined, biotinylated proteins are enriched on streptavidin-agarose beads, and subjected to an on-bead trypsin digestion. The IA-labeled peptides are released and analyzed by LC/LC-MS/MS. Heavy and light peptide pairs are quantified by their extracted MS1 peaks. (B) IA-alkyne structure and cysteine-labeling scheme. (C) The tobacco-etch virus (TEV) protease cleavable biotin-azide tag for isoTOP-ABPP.
Limitations in the current isoTOP-ABPP platform include the low coverage of the cellular cysteinome. Since low concentrations (100 uM) of IA-alkyne are used for proteome labeling, only 1000–2000 cellular cysteines are identified in a typical analysis. The subset of cysteine residues identified are those that demonstrate high reactivity with the IA electrophile, and have been shown to be enriched in functional cysteines [1]. However, some classes of functional cysteines remain intractable to IA labeling, and are therefore not typically captured in an isoTOP-ABPP analysis. Furthermore, reduced coverage of cysteine residues from low-abundant proteins, particular those localized within subcellular organelles, could limit the potential utility of isoTOP-ABPP for certain applications. Furthermore, cell lysates for isoTOP-ABPP are not typically treated with reducing agents, thereby limiting access to proteins that are highly susceptible to oxidation or aggregation. As discussed below, the development of new cysteine-reactive electrophiles, analytical methods, and cell-based profiling approaches, can serve to overcome some of these current limitations.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.